State AL
Clinical Trials in Alabama
Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.
Top Conditions in Alabama
NCT06588556 N/A
Recruiting
Improving Needs Among Older Adults
Condition
Critical Illness
Enrollment
350 pts
Location
United States
Sponsor
Duke University
NCT04396002 N/A
Recruiting
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adul...
Condition
Primary Open Angle Glaucoma
Enrollment
100 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT04955795 N/A
Recruiting
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
Condition
Hiv
Enrollment
308 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
NCT02325674 N/A
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Condition
Generalised Lipodystrophy
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Amryt Pharma
NCT05618353 Phase 4
Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Condition
Coronary Artery Disease
Enrollment
700 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07096674 Phase 2
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopa...
Condition
Narcolepsy Type 1
Enrollment
90 pts
Location
United States
Sponsor
Centessa Pharmaceuticals (UK)
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT06665256 Phase 2
Recruiting
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Condition
Idiopathic Inflammatory Myopathies
Enrollment
123 pts
Location
United States, France, Germany
Sponsor
Novartis Pharmaceuticals
NCT06252753 N/A
Recruiting
Observational Study Protocol: LIVER-R
Condition
Hepatobiliary Cancers
Enrollment
4,490 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06984341 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamic...
Condition
Systemic Lupus Erythematosus
Enrollment
162 pts
Location
United States
Sponsor
Genentech, Inc.
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT01429389 N/A
Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Condition
Down Syndrome
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Sequenom, Inc.
NCT05104983 Phase 2
Recruiting
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Condition
Tuberous Sclerosis Complex
Enrollment
64 pts
Location
United States
Sponsor
Darcy Krueger
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT03587961 EARLY_Phase 1
Recruiting
Personalized Theratyping Trial
Condition
Cystic Fibrosis
Enrollment
20 pts
Location
United States
Sponsor
George Solomon
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT06638801 N/A
Recruiting
Brain Uptrain to Improve Learning and Development
Condition
Term Infant
Enrollment
188 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05634369 Phase 1, Phase 2
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK...
Condition
Pediatric Sarcoma, Refractory
Enrollment
50 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastati...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT07006792 Phase 4
Recruiting
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Modera...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06866405 Phase 3
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vac...
Condition
RSV Infection
Enrollment
550 pts
Location
United States, Argentina, South Africa
Sponsor
Pfizer